IGALMI® (dexmedetomidine): FDA Approved First At-Home Treatment for Acute Agitation Associated with Schizophrenia, Schizoaffective Disorder & Bipolar Disorder
FDA approval · Clinical brief IGALMI Is Now FDA-Approved for At-Home Agitation. Who Should Get It, and Why Is the New Evidence About Safety, Not…